The SR proteins are essential metazoan pre-mRNA splicing factors that
can also influence the selection of alternative 5' splice sites in a c
oncentration-dependent manner. Their activity in alternative splicing
in vitro is antagonized by members of the hnRNP A/B family of proteins
. The opposite effects of members of these two families of antagonisti
c splicing factors in vitro and upon overexpression in vivo suggest th
at changes in their relative levels may be a natural mechanism for the
regulation of alternative splicing in vivo. One prediction of this mo
del is that the ratios of these antagonists should vary in different c
ell types and in other situations in which cellular or viral transcrip
ts are differentially spliced. We raised monoclonal antibodies specifi
c for SFS/ASF and used them to measure the abundance of SFS/ASF protei
n and its isoforms, its phosphorylation state in vivo and during splic
ing in vitro, and its association with the spliceosome. SF2/ASF exists
predominantly or exclusively in a highly phosphorylated state in vivo
in all cell types examined, and unphosphorylated protein was not dete
ctable. Unphosphorylated recombinant SFS/ASF becomes rapidly phosphory
lated under splicing conditions in HeLa cell extracts and associates s
tably with one or more exons of beta-globin pre-mRNA. This interaction
appears to persist through the splicing reaction and SF2/ASF remains
bound to spliced mRNA. We compared the distribution of SFS/ASF to that
of its antagonist, hnRNP Al, in different rat tissues and in immortal
and transformed cell lines. We found that the protein levels of these
antagonistic splicing factors vary naturally over a very wide range,
supporting the notion that changes in the ratio of these proteins can
affect alternative splicing of a variety of pre-mRNAs in vivo.